Lucas Svetlana bought JSPR
September 22, 2025 · Form 4 insider transaction
Lucas Svetlana bought 20,000 shares of Jasper Therapeutics, Inc. at $2.43 per share, a transaction worth $48.6K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
20,000
Price
$2.43
Total value
$48.6K
InsiderLucas Svetlana
RoleOfficer, Director
SecurityVoting Common Stock
Transaction codeP: Open-market purchase
Transaction dateSeptember 22, 2025
Filing dateSeptember 24, 2025
Shares owned after20,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each share of voting common stock was purchased together with an accompanying warrant to purchase one share of voting common stock in an underwritten public offering at a combined offering price of $2.43 per share of voting common stock and accompanying warrant.